|
1
|
Neesse A, Gress TM and Michl P:
Therapeutic targeting of apoptotic pathways: novel aspects in
pancreatic cancer. Curr Pharm Biotechnol. May 24–2011.(Epub ahead
of print).
|
|
2
|
Kato H, Ishikura H, Kawarada Y, Furuya M,
Kondo S and Yoshiki T: Anti-angiogenic treatment for peritoneal
dissemination of pancreas adenocarcinoma: a study using TNP-470.
Jpn J Cancer Res. 92:67–73. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saif MW: Anti-angiogenesis therapy in
pancreatic carcinoma. JOP. 7:163–173. 2006.PubMed/NCBI
|
|
4
|
Lin Y, Shi R, Wang X and Shen HM:
Luteolin, a flavonoid with potential for cancer prevention and
therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jaffe EA, Nachman RL, Becker CG and Minick
CR: Culture of human endothelial cells derived from umbilical
veins. Identification by morphologic and immunologic criteria. J
Clin Invest. 52:2745–2756. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cai X, Ye T, Liu C, et al: Luteolin
induced G2 phase cell cycle arrest and apoptosis on non-small cell
lung cancer cells. Toxicol In Vitro. 25:1385–1391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minchenko A, Bauer T, Salceda S and Caro
J: Hypoxic stimulation of vascular endothelial growth factor
expression in vitro and in vivo. Lab Invest. 71:374–379.
1994.PubMed/NCBI
|
|
8
|
Nagineni CN, Samuel W, Nagineni S, et al:
Transforming growth factor-β induces expression of vascular
endothelial growth factor in human retinal pigment epithelial
cells: involvement of mitogen-activated protein kinases. J Cell
Physiol. 197:453–462. 2003.
|
|
9
|
Das A and McGuire PG: Retinal and
choroidal angiogenesis: pathophysiology and strategies for
inhibition. Prog Retin Eye Res. 22:721–748. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McDougall SR, Anderson AR and Chaplain MA:
Mathematical modelling of dynamic adaptive tumour-induced
angiogenesis: clinical implications and therapeutic targeting
strategies. J Theor Biol. 241:564–589. 2006. View Article : Google Scholar
|
|
11
|
Joussen AM, Rohrschneider K, Reichling J,
Kirchhof B and Kruse FE: Treatment of corneal neovascularization
with dietary isoflavonoids and flavonoids. Exp Eye Res. 71:483–487.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bagli E, Stefaniotou M, Morbidelli L, et
al: Luteolin inhibits vascular endothelial growth factor-induced
angiogenesis; inhibition of endothelial cell survival and
proliferation by targeting phosphatidylinositol 3′-kinase activity.
Cancer Res. 64:7936–7946. 2004.PubMed/NCBI
|
|
13
|
Ramos S: Effects of dietary flavonoids on
apoptotic pathways related to cancer chemoprevention. J Nutr
Biochem. 18:427–442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang J, Hsu Y, Kuo P, Kuo Y, Chiang L and
Lin C: Increase of Bax/Bcl-XL ratio and arrest of cell cycle by
luteolin in immortalized human hepatoma cell line. Life Sci.
76:1883–1893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee HJ, Wang CJ, Kuo HC, Chou FP, Jean LF
and Tseng TH: Induction apoptosis of luteolin in human hepatoma
HepG2 cells involving mitochondria translocation of Bax/Bak and
activation of JNK. Toxicol Appl Pharmacol. 203:124–131. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee WJ, Wu LF, Chen WK, Wang CJ and Tseng
TH: Inhibitory effect of luteolin on hepatocyte growth
factor/scatter factor-induced HepG2 cell invasion involving both
MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact. 160:123–133.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim do Y, Jeong Y, Tyner AL and Park JH:
Induction of cell cycle arrest and apoptosis in HT-29 human colon
cancer cells by the dietary compound luteolin. Am J Physiol
Gastrointest Liver Physiol. 292:G66–G75. 2007.PubMed/NCBI
|
|
18
|
Plaumann B, Fritsche M, Rimpler H,
Brandner G and Hess RD: Flavonoids activate wild-type p53.
Oncogene. 13:1605–1614. 1996.PubMed/NCBI
|
|
19
|
Zhang Q, Zhao XH and Wang ZJ: Flavones and
flavonols exert cytotoxic effects on a human oesophageal
adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing
apoptosis. Food Chem Toxicol. 46:2042–2053. 2008. View Article : Google Scholar
|
|
20
|
Schutte ME, Boersma MG, Verhallen DA,
Groten JP and Rietjens IM: Effects of flavonoid mixtures on the
transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
through Caco-2 monolayers: an in vitro and kinetic modeling
approach to predict the combined effects on transporter inhibition.
Food Chem Toxicol. 46:557–566. 2008.PubMed/NCBI
|
|
21
|
Xavier CP, Lima CF, Preto A, Seruca R,
Fernandes-Ferreira M and Pereira-Wilson C: Luteolin, quercetin and
ursolic acid are potent inhibitors of proliferation and inducers of
apoptosis in both KRAS and BRAF mutated human colorectal cancer
cells. Cancer Lett. 281:162–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang SF, Yang WE, Chang HR, Chu SC and
Hsieh YS: Luteolin induces apoptosis in oral squamous cancer cells.
J Dent Res. 87:401–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yee SB, Lee JH, Chung HY, et al:
Inhibitory effects of luteolin isolated from Ixeris sonchifolia
Hance on the proliferation of HepG2 human hepatocellular carcinoma
cells. Arch Pharm Res. 26:151–156. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi RX, Ong CN and Shen HM: Luteolin
sensitizes tumor necrosis factor-alpha-induced apoptosis in human
tumor cells. Oncogene. 23:7712–7721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ando C, Takahashi N, Hirai S, et al:
Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent
activation of macrophages by inhibiting JNK activation. FEBS Lett.
583:3649–3654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jang S, Kelley KW and Johnson RW: Luteolin
reduces IL-6 production in microglia by inhibiting JNK
phosphorylation and activation of AP-1. Proc Natl Acad Sci USA.
105:7534–7539. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kimata M, Shichijo M, Miura T, Serizawa I,
Inagaki N and Nagai H: Effects of luteolin, quercetin and baicalein
on immunoglobulin E-mediated mediator release from human cultured
mast cells. Clin Exp Allergy. 30:501–508. 2000. View Article : Google Scholar : PubMed/NCBI
|
